Protein Description

Gene Symbol IGFBP5
Entrez ID 3488
Uniprot ID P24593
Description insulin like growth factor binding protein 5
Chromosomal Location chr2: 216,672,105-216,695,525
Ontology GO ID GO Term Definition Evidence

BP

GO:0001558

regulation of cell growth

Any process that modulates the frequency, rate, extent or direction of cell growth.

IEA

BP

GO:0001649

osteoblast differentiation

The process whereby a relatively unspecialized cell acquires the specialized features of an osteoblast, a mesodermal or neural crest cell that gives rise to bone.

IEA

BP

GO:0006006

glucose metabolic process

The chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. D-glucose is dextrorotatory and is sometimes known as dextrose; it is an important source of energy for living organisms and is found free as well as combined in homo- and hetero-oligosaccharides and polysaccharides.

IEA

BP

GO:0007165

signal transduction

The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.

NAS

BP

GO:0007565

female pregnancy

The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth.

IEA

BP

GO:0007568

aging

A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).

IEA

BP

GO:0010906

regulation of glucose metabolic process

Any process that modulates the rate, frequency or extent of glucose metabolism. Glucose metabolic processes are the chemical reactions and pathways involving glucose, the aldohexose gluco-hexose.

IEA

BP

GO:0014912

negative regulation of smooth muscle cell migration

Any process that stops, prevents, or reduces the frequency, rate or extent of smooth muscle cell migration.

IDA

BP

GO:0017148

negative regulation of translation

Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA.

IDA

BP

GO:0030336

negative regulation of cell migration

Any process that stops, prevents, or reduces the frequency, rate or extent of cell migration.

IDA

BP

GO:0031069

hair follicle morphogenesis

The process in which the anatomical structures of the hair follicle are generated and organized.

IEA

BP

GO:0035556

intracellular signal transduction

The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.

IEA

BP

GO:0042593

glucose homeostasis

Any process involved in the maintenance of an internal steady state of glucose within an organism or cell.

IEA

BP

GO:0043568

positive regulation of insulin-like growth factor receptor signaling pathway

Any process that increases the frequency, rate or extent of insulin-like growth factor receptor signaling.

IEA

BP

GO:0043569

negative regulation of insulin-like growth factor receptor signaling pathway

Any process that stops, prevents, or reduces the frequency, rate or extent of insulin-like growth factor receptor signaling.

IDA

BP

GO:0044267

cellular protein metabolic process

The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification.

TAS

BP

GO:0044342

type B pancreatic cell proliferation

The multiplication or reproduction of pancreatic B cells, resulting in the expansion of an pancreatic B cell population. Pancreatic B cell are cells of the pancreas that secrete insulin.

IEA

BP

GO:0045668

negative regulation of osteoblast differentiation

Any process that stops, prevents, or reduces the frequency, rate or extent of osteoblast differentiation.

IEA

BP

GO:0045926

negative regulation of growth

Any process that stops, prevents or reduces the rate or extent of growth, the increase in size or mass of all or part of an organism.

IEA

BP

GO:0048286

lung alveolus development

The process whose specific outcome is the progression of the alveolus over time, from its formation to the mature structure. The alveolus is a sac for holding air in the lungs; formed by the terminal dilation of air passageways.

IEA

BP

GO:0048662

negative regulation of smooth muscle cell proliferation

Any process that stops, prevents or reduces the rate or extent of smooth muscle cell proliferation.

IDA

BP

GO:0051146

striated muscle cell differentiation

The process in which a relatively unspecialized cell acquires specialized features of a striated muscle cell; striated muscle fibers are divided by transverse bands into striations, and cardiac and voluntary muscle are types of striated muscle.

IEA

BP

GO:0051897

positive regulation of protein kinase B signaling

Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.

IEA

BP

GO:0060056

mammary gland involution

The tissue remodeling that removes differentiated mammary epithelia during weaning.

IEA

BP

GO:0060416

response to growth hormone

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth hormone stimulus. Growth hormone is a peptide hormone that binds to the growth hormone receptor and stimulates growth.

ISS

BP

GO:0071320

cellular response to cAMP

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus.

IDA

BP

GO:0071407

cellular response to organic cyclic compound

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.

IDA

BP

GO:1901862

negative regulation of muscle tissue development

Any process that stops, prevents or reduces the frequency, rate or extent of muscle tissue development.

IEA

BP

GO:1904205

negative regulation of skeletal muscle hypertrophy

Any process that stops, prevents or reduces the frequency, rate or extent of skeletal muscle hypertrophy.

IEA

CC

GO:0005576

extracellular region

The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.

NAS|TAS

CC

GO:0005622

intracellular

The living contents of a cell; the matter contained within (but not including) the plasma membrane, usually taken to exclude large vacuoles and masses of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm.

IEA

CC

GO:0016942

insulin-like growth factor binding protein complex

A complex of proteins which includes the insulin-like growth factor (IGF) and a number of IGF-binding proteins. The complex plays a role in growth and development.

IC

CC

GO:0042567

insulin-like growth factor ternary complex

A complex of three proteins, which in animals is approximately 150kDa and consists of the insulin-like growth factor (IGF), the insulin-like growth factor binding protein-3 (IGFBP-3), or -5 (IGFBP-5) and an acid-labile subunit (ALS). The complex plays a role in growth and development.

IDA

MF

GO:0001968

fibronectin binding

Interacting selectively and non-covalently with a fibronectin, a group of related adhesive glycoproteins of high molecular weight found on the surface of animal cells, connective tissue matrices, and in extracellular fluids.

IBA

MF

GO:0005515

protein binding

Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).

IPI

MF

GO:0031994

insulin-like growth factor I binding

Interacting selectively and non-covalently with insulin-like growth factor I.

IPI

MF

GO:0031995

insulin-like growth factor II binding

Interacting selectively and non-covalently with insulin-like growth factor II.

IBA

Domain ID Description

IPR000716

Thyroglobulin type-1

IPR000867

Insulin-like growth factor-binding protein, IGFBP

IPR009030

Growth factor receptor cysteine-rich domain

IPR009168

Insulin-like growth factor binding protein

IPR012213

Insulin-like growth factor binding protein 5

IPR017891

Insulin-like growth factor binding protein, N-terminal, Cys-rich conserved site

IPR022321

Insulin-like growth factor-binding protein family 1-6, chordata

Pathway ID Pathway Term Pathway Source

WP289

Myometrial Relaxation and Contraction Pathways

WikiPathways

WP3850

Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling

WikiPathways

WP615

Senescence and Autophagy in Cancer

WikiPathways

h_ghrelinPathway

Ghrelin: Regulation of Food Intake and Energy Homeostasis

BioCarta

UMLS CUI UMLS Term

C0005695

Bladder Neoplasm

C0043094

Weight Gain

C1458155

Mammary Neoplasms

Tissue Cell Type

adrenal gland

glandular cells

cerebellum

cells in granular layer

No databases found.

Pubmed ID Author Year Title

15820804

Oksjoki et al.

2005

Molecular profiling of polycystic ovaries for markers of cell invasion and matrix turnover

22617121

Ouandaogo et al.

2012

Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation

22789864

Yan et al.

2012

Expression of apoptosis-related genes in the endometrium of polycystic ovary syndrome patients during the window of implantation

23824412

Piltonen et al.

2013

Mesenchymal Stem/Progenitors and Other Endometrial Cell Types From Women With Polycystic Ovary Syndrome (PCOS) Display Inflammatory and Oncogenic Potential

Gene Symbol Entrez ID Uniprot ID Score

F2

2147

P00734

0.62

PAPPA2

60676

Q9BXP8

0.62

ATP1A1

476

P05023

0.63

BAG6

7917

P46379

0.63

RASSF1

11186

Q9NS23

0.63

PNO1

56902

Q9NRX1

0.63

KPNB1

3837

Q14974

0.52

TF

7018

P02787

0.52

LTBP1

4052

Q14766

0.56

FHL1

2273

Q13642

0.63

FLNC

2318

Q14315

0.63

IGF1

3479

P05019

0.63

FN1

2335

P02751

0.67

ADAM12

8038

O43184

0.67

THBS1

7057

P07996

0.75

VTN

7448

P04004

0.75

SERPINE1

5054

P05121

0.85

IGF2

3481

P01344

0.86

IGFALS

3483

P35858

0.86

SPP1

6696

P10451

0.86

FHL2

2274

Q14192

0.89